• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险D部分对药物使用和自付费用的影响:一项系统评价。

Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.

作者信息

Park Young Joo, Martin Erika G

机构信息

Rockefeller College of Public Affairs & Policy, University at Albany-State University of New York, Albany, NY.

Nelson A. Rockefeller Institute of Government, State University of New York, Albany, NY.

出版信息

Health Serv Res. 2017 Oct;52(5):1685-1728. doi: 10.1111/1475-6773.12534. Epub 2016 Aug 1.

DOI:10.1111/1475-6773.12534
PMID:27480577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5583296/
Abstract

OBJECTIVE

To update a past systematic review on whether Medicare Part D changed drug utilization and out-of-pocket (OOP) costs overall and within subpopulations, and to identify evidence gaps.

DATA SOURCES/STUDY SETTING: Published and gray literature from 2010 to 2015 meeting prespecified screening criteria, including having a comparison group, and utilization or OOP cost outcomes.

STUDY DESIGN

We conducted a systematic literature review with a quality assessment.

DATA COLLECTION/EXTRACTION METHODS: For each study, we extracted information on study design, data sources, analytic methods, outcomes, and limitations. Because outcome measures vary across studies, we did a qualitative synthesis rather than meta-analysis.

PRINCIPAL FINDINGS

Sixty-five studies met screening criteria. Overall, Medicare Part D enrollees have increased drug utilization and decreased OOP costs, but coverage gaps limit the program's impact. Beneficiaries whose insurance becomes more generous after enrollment had disproportionately increased drug utilization and decreased OOP costs. Outcomes among dual-eligibles were mixed.

CONCLUSIONS

There is strong evidence on how Medicare Part D and the donut hole coverage gap affect utilization and OOP costs, but weak evidence on how effects vary among dual-eligibles or across diseases. Findings suggest that the Affordable Care Act's provisions to expand coverage and reduce the donut hole should improve patient outcomes.

摘要

目的

更新一项关于医疗保险D部分是否改变了总体及亚人群药物使用情况和自付费用(OOP)的既往系统评价,并识别证据空白。

数据来源/研究背景:2010年至2015年期间发表的及灰色文献,符合预先设定的筛选标准,包括设有对照组以及使用情况或自付费用结果。

研究设计

我们进行了一项带有质量评估的系统文献综述。

数据收集/提取方法:对于每项研究,我们提取了关于研究设计、数据来源、分析方法、结果及局限性的信息。由于不同研究的结果测量指标各异,我们进行了定性综合分析而非荟萃分析。

主要发现

65项研究符合筛选标准。总体而言,医疗保险D部分的参保者药物使用增加,自付费用降低,但保险覆盖缺口限制了该计划的影响。参保后保险福利变得更优厚的受益人群药物使用增加和自付费用降低的比例过高。双重资格受益人的结果参差不齐。

结论

有充分证据表明医疗保险D部分及环形缺口保险覆盖如何影响使用情况和自付费用,但关于双重资格受益人或不同疾病间影响差异的证据不足。研究结果表明,《平价医疗法案》中扩大保险覆盖范围和缩小环形缺口的条款应能改善患者结局。

相似文献

1
Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.医疗保险D部分对药物使用和自付费用的影响:一项系统评价。
Health Serv Res. 2017 Oct;52(5):1685-1728. doi: 10.1111/1475-6773.12534. Epub 2016 Aug 1.
2
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.《降低通胀法案》下患有痴呆症的医疗保险受益人的自付药品费用变化:一项模拟研究
Value Health. 2025 Apr;28(4):553-561. doi: 10.1016/j.jval.2025.01.008. Epub 2025 Jan 27.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries.医疗保险受益人的补贴药物覆盖范围丧失与死亡率
N Engl J Med. 2025 May 29;392(20):2025-2034. doi: 10.1056/NEJMsa2414435. Epub 2025 May 14.
2
Comparison of Financial Hardship and Healthcare Utilizations Associated with Cancer in the United States Medicare Programs during the COVID-19 Pandemic.2019年冠状病毒病疫情期间美国医疗保险计划中与癌症相关的经济困难和医疗服务利用情况比较
Healthcare (Basel). 2024 May 20;12(10):1049. doi: 10.3390/healthcare12101049.
3
Healthcare Cost Burden and Self-Reported Frequency of Depressive/Anxious Feelings in Older Adults.老年人的医疗费用负担与抑郁/焦虑情绪的自述频率。
J Gerontol Soc Work. 2024 Apr;67(3):349-368. doi: 10.1080/01634372.2024.2326683. Epub 2024 Mar 7.
4
What is the quantity, quality and type of systematic review evidence available to inform the optimal prescribing of statins and antihypertensives? A systematic umbrella review and evidence and gap map.有哪些数量、质量和类型的系统评价证据可用于为他汀类药物和抗高血压药物的最佳处方提供信息?系统评价伞状综述及证据和差距图。
BMJ Open. 2024 Feb 24;14(2):e072502. doi: 10.1136/bmjopen-2023-072502.
5
Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke.增加医疗保险覆盖缺口中外购费用对抗凝药物停药和卒中的意外后果。
Adv Ther. 2023 Oct;40(10):4523-4544. doi: 10.1007/s12325-023-02620-z. Epub 2023 Aug 11.
6
The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data.政府报销谈判对中国靶向抗癌药物使用和成本的影响:基于国家医疗保险数据的队列研究。
J Glob Health. 2023 Aug 11;13:04083. doi: 10.7189/jogh.13.04083.
7
Do High-Deductible Health Plans Incentivize Changing the Timing of Substance Use Disorder Treatment?高自付额健康计划是否激励改变物质使用障碍治疗的时机?
Med Care Res Rev. 2023 Oct;80(5):530-539. doi: 10.1177/10775587231180667. Epub 2023 Jun 21.
8
Trends in anti-HER2 drugs consumption and influencing factors.抗 HER2 药物的使用趋势及影响因素。
Front Public Health. 2022 Sep 8;10:944071. doi: 10.3389/fpubh.2022.944071. eCollection 2022.
9
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation.表皮生长因子受体酪氨酸激酶抑制剂的消费和成本趋势:报销和国家价格谈判的影响。
BMC Health Serv Res. 2022 Apr 1;22(1):431. doi: 10.1186/s12913-022-07868-9.
10
A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.系统综述 umbrella review 处方药保险与费用分担与药物使用、卫生服务使用和健康的关联。
BMC Health Serv Res. 2022 Mar 3;22(1):297. doi: 10.1186/s12913-022-07554-w.

本文引用的文献

1
Medicare Part D coverage gap: race, gender, and cost-related medication nonadherence.医疗保险D部分覆盖缺口:种族、性别与费用相关的药物治疗不依从性
Soc Work Public Health. 2015;30(6):473-85. doi: 10.1080/19371918.2015.1052607. Epub 2015 Aug 6.
2
Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.医疗保险D部分实施前后青光眼患者与费用相关的药物治疗不依从性和节省费用行为
JAMA Ophthalmol. 2015 Sep;133(9):985-96. doi: 10.1001/jamaophthalmol.2015.1671.
3
Did Medicare Part D reduce disparities?医疗保险D部分是否减少了差异?
Am J Manag Care. 2015 Feb;21(2):119-28.
4
Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries.美国医疗保险受益人群中用于类风湿关节炎的生物性改善病情抗风湿药物的使用情况及支出
Arthritis Care Res (Hoboken). 2015 Sep;67(9):1210-1218. doi: 10.1002/acr.22580.
5
Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.药物覆盖范围慷慨程度的变化与未经治疗的严重精神疾病:从医疗补助计划过渡到医疗保险部分 D。
JAMA Psychiatry. 2015 Feb;72(2):179-88. doi: 10.1001/jamapsychiatry.2014.1259.
6
Impact of Medicare Part D on coverage, access, and disparities among new jersey seniors.医疗保险D部分对新泽西州老年人的保险覆盖、医疗可及性及差异的影响
Med Care Res Rev. 2015 Apr;72(2):127-48. doi: 10.1177/1077558714563762. Epub 2014 Dec 28.
7
Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.有和没有低收入补贴的医疗保险D部分受益人的处方药支出模式和药物依从性
BMC Health Serv Res. 2014 Dec 20;14:665. doi: 10.1186/s12913-014-0665-3.
8
Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.医疗保险D部分低收入成本补贴计划的登记与冠状动脉支架置入术后氯吡格雷用药依从性增加之间的关联。
Pharmacotherapy. 2014 Dec;34(12):1230-8. doi: 10.1002/phar.1502. Epub 2014 Oct 14.
9
Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.在接受医疗保险处方药计划(Medicare Part D)的透析患者中,药物治疗的依从性和持续性:福利类型和福利阶段的比较。
J Manag Care Spec Pharm. 2014 Aug;20(8):862-76. doi: 10.18553/jmcp.2014.20.8.862.
10
Impact of Medicare Part D on out-of-pocket drug costs and medical use for patients with cancer.医疗保险部分 D 对癌症患者自付药物费用和医疗使用的影响。
Cancer. 2014 Nov 1;120(21):3378-84. doi: 10.1002/cncr.28898. Epub 2014 Jun 24.